A citation-based method for searching scientific literature

Carlos Cepeda, Kerry P S Murphy, Martin Parent, Michael S Levine. Prog Brain Res 2014
Times Cited: 75







List of co-cited articles
899 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
24

Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
735
22

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
20

Role of brain-derived neurotrophic factor in Huntington's disease.
Chiara Zuccato, Elena Cattaneo. Prog Neurobiol 2007
383
17

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
585
16

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
16

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
N Ginovart, A Lundin, L Farde, C Halldin, L Bäckman, C G Swahn, S Pauli, G Sedvall. Brain 1997
190
14

Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
Michael A Johnson, Vignesh Rajan, Charles E Miller, R Mark Wightman. J Neurochem 2006
95
14

Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility.
Jane Y Chen, Elizabeth A Wang, Carlos Cepeda, Michael S Levine. Front Neurosci 2013
93
14

Huntington's disease.
Francis O Walker. Lancet 2007
14

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
R L Albin, A Reiner, K D Anderson, L S Dure, B Handelin, R Balfour, W O Whetsell, J B Penney, A B Young. Ann Neurol 1992
259
14

Striatal neurochemical changes in transgenic models of Huntington's disease.
Marjorie A Ariano, Neil Aronin, Marian Difiglia, Danilo A Tagle, David R Sibley, Blair R Leavitt, Michael R Hayden, Michael S Levine. J Neurosci Res 2002
72
13

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
J A Bibb, Z Yan, P Svenningsson, G L Snyder, V A Pieribone, A Horiuchi, A C Nairn, A Messer, P Greengard. Proc Natl Acad Sci U S A 2000
236
13

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
934
13



Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.
Carlos Cepeda, Laurie Galvan, Sandra M Holley, Shilpa P Rao, Véronique M André, Elian P Botelho, Jane Y Chen, Joseph B Watson, Karl Deisseroth, Michael S Levine. J Neurosci 2013
80
12

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
246
10

Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice.
A Petersén, Z Puschban, J Lotharius, B NicNiocaill, P Wiekop, W T O'Connor, P Brundin. Neurobiol Dis 2002
67
11

Differential electrophysiological changes in striatal output neurons in Huntington's disease.
Véronique M André, Carlos Cepeda, Yvette E Fisher, My Huynh, Nora Bardakjian, Sumedha Singh, X William Yang, Michael S Levine. J Neurosci 2011
96
10


Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.
Y P Deng, R L Albin, J B Penney, A B Young, K D Anderson, A Reiner. J Chem Neuroanat 2004
143
10

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.
J H Cha, C M Kosinski, J A Kerner, S A Alsdorf, L Mangiarini, S W Davies, J B Penney, G P Bates, A B Young. Proc Natl Acad Sci U S A 1998
411
10

Corticostriatal synaptic adaptations in Huntington's disease.
Joshua L Plotkin, D James Surmeier. Curr Opin Neurobiol 2015
70
11

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
200
10

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
790
10

Heterogeneous dopamine receptor changes in early and late Huntington's disease.
E K Richfield, C F O'Brien, T Eskin, I Shoulson. Neurosci Lett 1991
78
10


Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
925
10



Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology.
George J Yohrling, George C-T Jiang, Molly M DeJohn, David W Miller, Anne B Young, Kent E Vrana, Jang-Ho J Cha. Brain Res Mol Brain Res 2003
46
15

Hyperdopaminergic status in experimental Huntington disease.
Ali Jahanshahi, Rinske Vlamings, Ahmet Hilmi Kaya, Lee Wei Lim, Marcus L F Janssen, Sonny Tan, Veerle Visser-Vandewalle, Harry W M Steinbusch, Yasin Temel. J Neuropathol Exp Neurol 2010
32
21

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.
G Schilling, M W Becher, A H Sharp, H A Jinnah, K Duan, J A Kotzuk, H H Slunt, T Ratovitski, J K Cooper, N A Jenkins,[...]. Hum Mol Genet 1999
583
9

Dopamine and glutamate in Huntington's disease: A balancing act.
Véronique M André, Carlos Cepeda, Michael S Levine. CNS Neurosci Ther 2010
97
9

Impaired dopamine release and uptake in R6/1 Huntington's disease model mice.
Andrea N Ortiz, Benjamin J Kurth, Gregory L Osterhaus, Michael A Johnson. Neurosci Lett 2011
25
28

Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.
Catherine Bédard, Marie-Josée Wallman, Emmanuelle Pourcher, Peter V Gould, André Parent, Martin Parent. Parkinsonism Relat Disord 2011
64
10

Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
Joshua L Plotkin, Michelle Day, Jayms D Peterson, Zhong Xie, Geraldine J Kress, Igor Rafalovich, Jyothisri Kondapalli, Tracy S Gertler, Marc Flajolet, Paul Greengard,[...]. Neuron 2014
122
9

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
232
9

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen, Jukka Puoliväli, Susan J Hendricks, Jack R Glaser, Amyaouch Bradaia, Kristian Wadel, Chrystelle Touller, Outi Kontkanen,[...]. PLoS One 2012
147
9

The corticostriatal pathway in Huntington's disease.
Carlos Cepeda, Nanping Wu, Véronique M André, Damian M Cummings, Michael S Levine. Prog Neurobiol 2007
232
9

Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia.
Anton Reiner, Evan Shelby, Hongbing Wang, Zena Demarch, Yunping Deng, Natalie Hart Guley, Virginia Hogg, Richard Roxburgh, Lynette J Tippett, Henry J Waldvogel,[...]. Mov Disord 2013
59
11

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
439
9

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
604
9

Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery.
Chiara Zuccato, Daniel Liber, Catarina Ramos, Alessia Tarditi, Dorotea Rigamonti, Marzia Tartari, Marta Valenza, Elena Cattaneo. Pharmacol Res 2005
142
9



Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
9

Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease.
Sandra M Holley, Prasad R Joshi, Anna Parievsky, Laurie Galvan, Jane Y Chen, Yvette E Fisher, My N Huynh, Carlos Cepeda, Michael S Levine. eNeuro 2015
36
19


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.